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Desmoid tumours are generally very rare but occur
about 100 times more frequently in the colorectal cancer
predisposition syndrome familial adenomatous poly-
posis (MIM 175100), being represented in about 10% of
patients. In addition to desmoid disease occurring in
familial adenomatous polyposis (FAP) there exist familial
infiltrative fibromatosis (MIM 135290) kindreds where
there is no evidence of FAP. Previously we have de-
scribed a kindred with familial infiltrative fibromatosis
(FIF) in which desmoid tumours were associated with
nonpolyposis colorectal cancer. FAP is caused by muta-
tions in the APC gene and various genotype–phenotype
relationships have been defined including reports that
colorectal polyposis is less severe with mutations 5′ to
codon 157 and that the risk of desmoid tumours is high
in FAP patients with APC gene mutations between co-
dons 1444 and 1598. There is relatively little information
on the phenotype of APC gene mutations 3′ to codon
1598; however, one large family has been reported with
a mutation at codon 1987 which presents with a highly
variable phenotype which includes desmoid disease. We
screened our original FIF kindred and three further fam-
ilies with a similar phenotype for mutations in the APC
gene. A 4 bp frameshift deletion in codon 1962 was
identified in the original FIF kindred and two further ap-
parently unrelated families. Haplotype analysis suggests
a common origin for the APC mutation in all three fam-
ilies. Affected individuals had no evidence of congenital
hypertrophy of the retinal pigment epithelium. Colorectal
polyposis was variable, and most affected patients had
either none or a few late onset polyps. These findings
demonstrate (i) that FAP and FIF are allelic, and (ii) that
APC gene mutations which truncate the APC protein dis-
tal to the beta-catenin binding domain are associated
with desmoid tumours, absent CHRPE and variable but
attenuated polyposis expression.
INTRODUCTION
Desmoid tumours (infiltrative fibromatosis) are rare but they occur
relatively frequently (between 5 and 10%) in patients with the
autosomal dominantly inherited familial cancer syndrome, familial
adenomatous polyposis coli (MIM 175100) (1). Familial adenoma-
tous polyposis (FAP) is caused by germline mutations in the APC
gene mutation and is characterised by the development of multiple
colorectal polyps (>100), duodenal polyps and extra-intestinal
manifestations such as congenital hypertrophy of the retinal pigment
epithelium (CHRPE), epidermoid cysts, desmoid tumours and
osteoma (2–5). In 1992 we described a unique four-generation
family with familial infiltrative fibromatosis (FIF) (MIM 135290)
(6). Affected individuals developed desmoid tumours or nonpolypo-
sis colorectal cancer, but other features of FAP were not detected,
therefore we believed this family to be a variation of the hereditary
nonpolyposis colorectal cancer syndrome (HNPCC).
The APC gene is ∼8500 bp in size and encodes a protein of 2843
amino acids. Most germline APC mutations are predicted to
truncate the APC protein and occur 5′ to codon 1598, so
mutations in the 3′ coding region are rare (5,7,8). The colorectal
and extra-intestinal manifestations of FAP have been correlated
with the position of the APC gene mutation (7,9). Mutations 5′ to
codons 157 may cause no or few polyps, referred to as the
attenuated FAP phenotype or AAPC (10). CHRPE is usually
absent in patients with mutations 5′ of codon 302 and 3′ of codon
1444 (11,12). Truncation of the APC protein between codons
1285 and 1465 has been associated with severe polyposis (5,13).
Desmoid tumours are frequent in FAP patients with mutations in
codons 1445–1578 (7,8,12,14). Mutations 3′ of codon 1578 are
rare in FAP and have not been associated with a distinct
phenotype. In a previous study we were unable to identify a
5′ APC gene mutation in familial desmoid kindreds (15) and we
hypothesised that familial desmoid tumours with few colorectal
polyps might be caused by 3′ APC mutations. We therefore
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Figure 1. Pedigrees of the four families. Further details of the relevant patients are given in the text. DNA was analysed from all patients indicated with an *.
screened our original FIF kindred and three further families with
desmoid tumours without classical FAP for germline APC gene
mutations. Intriguingly, an identical mutation at codon 1962 was
found in three of the four apparently unrelated kindreds.
RESULTS
Clinical phenotype
Pedigree and clinical details are summarised in Figure 1. All four
families were thought to be unrelated, although families 1–3 were
from eastern England. Families 1, 2 and 3 contained two or more
patients with desmoid tumours and family 4 a single case
(see Fig. 1). Family 1 was described previously and displayed a
four-generation history of desmoid tumours and nonpolyposis
colorectal cancer with no other evidence of intestinal (duodenal
polyps) or extra-intestinal features (osteomas, CHRPE) of FAP.
In family 2 the proband had multiple thoracic wall desmoid
tumours but no colorectal polyps at age 30 years. Her mother had
an intra-abdominal desmoid and a carcinoma of the colon and 30
colorectal polyps at age 31 years. A maternal aunt had an
intra-abdominal desmoid age 60 years and the maternal grand-
mother had a colectomy for 200 colonic polyps at age 66 years.
In family 3, two individuals had had intra-abdominal desmoids
without features of FAP, but multiple intervening relatives had a
history of colorectal cancer and one relative had a history of
multiple gastric polyposis. In family 4 the proband had an
intra-abdominal desmoid resected age 7 years and is free of
recurrence at age 13 years. His father had a normal colonoscopy
at age 50 years, but a paternal uncle and three further relatives
were reported to have colorectal cancer, without polyposis.
Molecular genetic analysis
Evidence of a similar protein truncating APC gene mutation
between codons 1555 and 2256 was detected in families 1, 2 and
3 with the in vitro translation assay. Direct sequencing of genomic
DNA revealed an identical 4 bp deletion at nucleotides
5844–5847 (codon 1962) of the APC sequence (Fig. 2). The
deletion mutation was detected in all patients from families 1–3
for whom DNA was available (see Fig. 1). To determine if this
recurrent mutation was likely to be the result of a founder effect
or a ‘mutation hot spot’, a disease associated haplotype was
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Figure 2. Sequence analysis of the mutated region in exon 15. (A) Normal chromatogram of the sequence between codons 1950 and 1980. (B) Mutated sequence
between showing overlapping mutated and normal sequence between codons 1950 and 1980.
constructed at three polymorphic sites within or close to the APC
gene (D5S82, D5S346 and APC-RsaI) (3,24,25). The mutation
associated haplotype in families 1, 2 and 3 was consistent with a
common origin and this haplotype was not present in family 4.
DISCUSSION
The identification of a germline APC gene mutation in our original
kindred with FIF has confirmed our original suggestion that this
disorder might be allelic with FAP. In addition, the identification of
a further genotype–phenotype correlation provides more evidence
that the APC protein has tissue-specific functions. The presence of
an identical mutation in three kindreds was unexpected, in view of
the inter-familial variations in phenotype with no evidence of
colorectal polyposis in family 1 but up to ∼200 polyps (at age 66)
in an individual in family 2. Founder mutations are uncommon in
classical FAP, and although the risk of colorectal cancer in the 3′
APC gene mutation families appears to be less than in classical FAP,
early death from locally invasive desmoid tumours may occur.
Recently, Eccles et al. (16) have reported a high frequency of
desmoid tumours with very late onset of and incomplete penetrance
of intestinal polyposis in a large kindred with an APC mutation at
codon 1924. Thus it appears that APC mutations in the 3′ region of
exon 15 are associated with a high risk of desmoid tumour and a
relatively low, but variable, incidence of colorectal adenomatous
polyps. The inter-familial variations in phenotype observed between
kindreds with identical mutations may result from modifier effects
(17), although further studies will be needed to investigate this. We
did not identify a mutation in family 4, but cannot exclude a
germline APC gene mutation as the PTT we employed can, in some
circumstances, fail to detect truncating mutations and would not
detect missense mutations or small in-frame deletions (18).
Although the precise function of the APC protein is unknown,
evidence suggests that it interacts with alpha and beta-catenins and
appears to be associated with the microtubule cytoskeleton (19–21).
Heptad repeat regions within the APC protein may form coiled coil
structures and allow the APC protein to associate with itself and
other proteins. The formation of a heterodimer between wild-type
and truncated APC protein is thought to be more deleterious than a
50% reduction in APC protein levels. Hence 5′ APC mutations
(<codon 157) which result in short truncated proteins and which are
predicted not to dimerise with wild-type protein have been
associated with a less severe phenotype than seen in classical FAP
(10,22,23). Most APC mutations in classical FAP occur in the 5′
half of the coding sequence and mutations beyond codon 1597 are
reported rarely (<2.5% of cases) (5). We have demonstrated that 3′
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APC mutations which would be predicted to produce large truncated
proteins lacking the tubulin-binding and basic domains in the
carboxy region do not produce florid colorectal polyposis. Further
studies are needed to (i) delineate the phenotype of 3′ APC gene
mutations, (ii) determine the precise relationship between the
position of 3′ APC gene mutations and severity of colonic polyposis
and (iii) elucidate the effect of particular mutations on the stability
and tissue specific functions of the APC protein. More information
may lead to a better understanding of the molecular pathogenesis of
desmoid tumours and provide insights into the structure–function
relationships of the APC protein.
MATERIALS AND METHODS
The in vitro protein translation assay was performed on high
molecular weight genomic DNA as described previously (18).
Exon 15 of the APC gene was divided into four overlapping
sequences and PCR amplification was performed in a 25 µl
reaction volume using 200 ng of genomic DNA as template under
standard conditions. The samples were cycled at 94C 30 s, 55C
30 s, 72C 2 min, 35 times. A 1.5 µl aliquot was then taken and
used as the template in an in vitro transcription and translation
reaction using a TNT T7 coupled reticulocyte lysate system
(Promega, Madison, WI). For labelling purposes, 0.2 µl of
EasyTag35-S Methionine (NEN; Boston, Mass.) was included in
each reaction. Labelled APC protein products were size fraction-
ated on 12% sodium dodecyl sulphate polyacrylamide gels
(SDS-PAGE) gels (National Diagnostics, Atlanta, Georgia),
fixed, dried and exposed to Biomax film (Kodak, Rochester NY).
Samples with detectable truncated proteins were investigated
further by direct cycle sequencing using Thermo Sequenase
(Amersham, Buckinghamshire) and a LiCor automated se-
quencer (LiCor, Lincoln, Nebraska). Primers were end labelled
with IRD-41 (LiCor Lincoln, Nebraska) and used directly in the
cycle sequencing reaction. Cycle sequencing parameters were
93C 30 s, 55C 30 s and 72C 1 min, 21 times.
Haplotype analysis was performed at microsatellite loci D5S82
(24) and D5S346 (25), close to APC, and at the APC-RsaI RFLP
in exon 11 (3). For the microsatellite analysis, one primer of each
pair was end-labelled with γ-32P ATP using T4 polynucleotide
kinase (New England Biolabs, Hitchin UK), and incorporated into
the appropriate PCR reaction mix (final Mg++ concentration of 1.5
mM, 60 ng each primer, approximately 300 ng DNA). Annealing
temperatures of 48C for D5S82 and 55C for D5S346 were used.
PCR products were electrophoresed on 6% denaturing polyacryl-
amide gels for 3–4 h, autoradiography was performed for 1–3 days.
For the APC-RsaI RFLP, approximately 300 ng DNA was amplified
in a final volume of 25 µl at a final Mg++ concentration of 2.5 mM,
using 100 ng each of primers 11F (5′-GATGATTGTCTTTTTCCT-
CTTGC-3′) and 11R (5′- CTGAGCTATCTTAAGAAATAC ATG-
3′). Cycle conditions were 95C 5 min, then 30 cycles of 57C 45 s,
72C 45 s, 96C 45 s. Products were digested with RsaI (Stratagene,
Cambridge, UK), electrophoresed on 2% NuSieve/1% agarose gels,
and scored for the presence or absence of the T→C polymorphism
which creates an RsaI site and thus allows digestion of the 215 bp
PCR product to 85 bp and 130 bp.
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